These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2228022)

  • 1. Generation and characterization of a neutralizing rat anti-rmTNF-alpha monoclonal antibody.
    Lucas R; Heirwegh K; Neirynck A; Remels L; Van Heuverswyn H; De Baetselier P
    Immunology; 1990 Oct; 71(2):218-23. PubMed ID: 2228022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.
    Sheehan KC; Ruddle NH; Schreiber RD
    J Immunol; 1989 Jun; 142(11):3884-93. PubMed ID: 2469726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-human recombinant tumor necrosis factor alpha (TNF alpha) monoclonal antibody recognizes an epitope in feline TNF alpha.
    Aguirre A; Escobar A; Ferreira V; Molina MC; Ferreira A; Aguillón JC
    Vet Res; 2003; 34(2):177-84. PubMed ID: 12657209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
    Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW
    J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors.
    Rasmussen CA; Pace JL; Banerjee S; Phillips TA; Hunt JS
    Placenta; 1999; 20(2-3):213-22. PubMed ID: 10195744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis.
    Opal SM; Cross AS; Sadoff JC; Collins HH; Kelly NM; Victor GH; Palardy JE; Bodmer MW
    J Clin Invest; 1991 Sep; 88(3):885-90. PubMed ID: 1885775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of monoclonal antibodies to human tumor necrosis factor alpha (TNF alpha).
    McLaughlin PJ; Elwood NJ; Russell SM; Andrew SM; McKenzie IF
    Anticancer Res; 1992; 12(4):1243-6. PubMed ID: 1503416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor alpha production by polymorphonuclear neutrophils treated with mouse anti-human CD19 monoclonal antibody.
    Nishimura M
    Cell Biochem Funct; 2004; 22(4):207-11. PubMed ID: 15248179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA.
    Kim KH; Shim JH; Seo EH; Cho MC; Kang JW; Kim SH; Yu DY; Song EY; Lee HG; Sohn JH; Kim J; Dinarello CA; Yoon DY
    J Immunol Methods; 2008 Apr; 333(1-2):38-50. PubMed ID: 18252253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prepared and screened a modified TNF-alpha molecule as TNF-alpha autovaccine to treat LPS induced endotoxic shock and TNF-alpha induced cachexia in mouse.
    Wan Y; Xue X; Li M; Zhang X; Qin X; Zhang C; You Y; Wang W; Jiang C; Wu S; Liu Y; Zhu W; Ran Y; Zhang Z; Han W; Zhang Y
    Cell Immunol; 2007 Apr; 246(2):55-64. PubMed ID: 17592730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characterization of neutralizing activity of murine monoclonal antibodies for construction of anti-human TNF chimeric antibody].
    Zhu CS; Ouyang WM; Liu XS; Cao YX; Zhao N; Jin BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov; 19(6):576-9. PubMed ID: 15182654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis.
    Echtenacher B; Falk W; Männel DN; Krammer PH
    J Immunol; 1990 Dec; 145(11):3762-6. PubMed ID: 2246512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA.
    Lucas C; Bald LN; Fendly BM; Mora-Worms M; Figari IS; Patzer EJ; Palladino MA
    J Immunol; 1990 Sep; 145(5):1415-22. PubMed ID: 2384664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of monoclonal antibodies to murine macrophage colony-stimulating factor.
    Lokeshwar BL; Lin HS
    J Immunol; 1988 Jul; 141(2):483-8. PubMed ID: 2454994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies.
    Hommel-Berrey G; Bochan M; Brahmi Z
    Nat Immun; 1994; 13(6):301-14. PubMed ID: 7894201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tumor necrosis factor on the antitumor efficacy and toxicity of aminopterin-monoclonal antibody conjugates: parameters for optimization of therapy.
    Russell SM; Krauer KG; McKenzie IF; Pietersz GA
    Cancer Res; 1990 Sep; 50(18):6028-33. PubMed ID: 2393867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of growth-related protein in lipopolysaccharide-induced rabbit arthritis: cooperation between growth-related protein and IL-8, and interrelated regulation among TNFalpha, IL-1, IL-1 receptor antagonist, IL-8, and growth-related protein.
    Matsukawa A; Yoshimura T; Fujiwara K; Maeda T; Ohkawara S; Yoshinaga M
    Lab Invest; 1999 May; 79(5):591-600. PubMed ID: 10334570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rat monoclonal antibody that binds specifically to mouse T lymphoblasts and inhibits IL 2 receptor functions: a putative anti-IL 2 receptor antibody.
    Osawa H; Diamantstein T
    J Immunol; 1984 May; 132(5):2445-50. PubMed ID: 6425405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient immobilization of a ligand antibody with high antigen-binding activity by use of a polystyrene-binding peptide and an intelligent microtiter plate.
    Kumada Y; Hamasaki K; Shiritani Y; Ohse T; Kishimoto M
    J Biotechnol; 2009 Jun; 142(2):135-41. PubMed ID: 19501265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.